Adma Biologics (ADMA) Return on Sales (2011 - 2025)

Adma Biologics' Return on Sales history runs 14 years deep, the most recent figure standing at 0.01% for Q4 2025.

• Quarterly Return on Sales fell 1.0% year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.01% for Q4 2025 at Adma Biologics, down from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q4 2024 and bottomed at 0.01% in Q1 2021.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2021 — Return on Sales grew 2 bps — and 2025, when it fell 1 bps.
• Adma Biologics' Return on Sales stood at 0.0% in 2021, then climbed by 18 bps to 0.0% in 2022, then soared by 138 bps to 0.0% in 2023, then surged by 196 bps to 0.0% in 2024, then sank by 326 bps to 0.01% in 2025.
• Business Quant data shows ADMA's Return on Sales at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.